My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 843

    1.

    Sulfonylurea compounds uncouple the glucose dependence of the insulinotropic effect of glucagon-like peptide 1.

    de Heer J, Holst JJ.

    Diabetes. 2007 Feb;56(2):438-43.PMID: 17259389 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.

    Gutniak MK, Juntti-Berggren L, Hellström PM, Guenifi A, Holst JJ, Efendic S.

    Diabetes Care. 1996 Aug;19(8):857-63.PMID: 8842604 [PubMed - indexed for MEDLINE]Related articles

    3.

    Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.

    de Heer J, Rasmussen C, Coy DH, Holst JJ.

    Diabetologia. 2008 Dec;51(12):2263-70. Epub 2008 Sep 16.PMID: 18795252 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulinotropic hormone glucagon-like peptide-1-(7-37) appears not to augment insulin-mediated glucose uptake in young men during euglycemia.

    Ryan AS, Egan JM, Habener JF, Elahi D.

    J Clin Endocrinol Metab. 1998 Jul;83(7):2399-404.PMID: 9661618 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide.

    McClenaghan NH, Flatt PR, Ball AJ.

    J Endocrinol. 2006 Sep;190(3):889-96.PMID: 17003289 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent, A-4166, in perfused rat pancreas.

    Fujitani S, Ikenoue T, Akiyoshi M, Maki T, Yada T.

    Metabolism. 1996 Feb;45(2):184-9.PMID: 8596487 [PubMed - indexed for MEDLINE]Related articles

    7.

    Glucagon-like peptide 1 increases insulin sensitivity in depancreatized dogs.

    Sandhu H, Wiesenthal SR, MacDonald PE, McCall RH, Tchipashvili V, Rashid S, Satkunarajah M, Irwin DM, Shi ZQ, Brubaker PL, Wheeler MB, Vranic M, Efendic S, Giacca A.

    Diabetes. 1999 May;48(5):1045-53.PMID: 10331409 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers.

    Nauck MA, Heimesaat MM, Behle K, Holst JJ, Nauck MS, Ritzel R, Hüfner M, Schmiegel WH.

    J Clin Endocrinol Metab. 2002 Mar;87(3):1239-46.PMID: 11889194 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.

    Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.

    Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Altered glucose dependence of glucagon-like peptide I(7-36)-induced insulin secretion from the Zucker (fa/fa) rat pancreas.

    Jia X, Elliott R, Kwok YN, Pederson RA, McIntosh CH.

    Diabetes. 1995 May;44(5):495-500.PMID: 7729605 [PubMed - indexed for MEDLINE]Related articles

    11.

    Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo.

    Hargrove DM, Nardone NA, Persson LM, Andrews KM, Shepherd KL, Stevenson RW, Parker JC.

    Metabolism. 1996 Mar;45(3):404-9.PMID: 8606650 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of glucagonlike peptide I-(7-36) on release of insulin, glucagon, and somatostatin by rat pancreatic islet cell monolayer cultures.

    D'Alessio DA, Fujimoto WY, Ensinck JW.

    Diabetes. 1989 Dec;38(12):1534-8.PMID: 2573553 [PubMed - indexed for MEDLINE]Related articles

    13.

    Effect of tolbutamide on insulin, glucagon, and somatostatin release from the diabetic rat pancreas with special reference to glucose concentration.

    Kadowaki S, Taminato T, Chiba T, Nozawa M, Fujita T, Norman AW.

    Endocrinology. 1983 Jun;112(6):2187-92.PMID: 6133743 [PubMed - indexed for MEDLINE]Related articles

    14.

    Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro.

    Guenifi A, Ahrén B, Abdel-Halim SM.

    Pancreas. 2001 Jan;22(1):58-64.PMID: 11138972 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glucose-sensing in glucagon-like peptide-1-secreting cells.

    Reimann F, Gribble FM.

    Diabetes. 2002 Sep;51(9):2757-63.PMID: 12196469 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Galanin inhibits glucagon-like peptide-1 secretion through pertussis toxin-sensitive G protein and ATP-dependent potassium channels in rat ileal L-cells.

    Saïfia S, Chevrier AM, Bosshard A, Cuber JC, Chayvialle JA, Abello J.

    J Endocrinol. 1998 Apr;157(1):33-41.PMID: 9614355 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effects of pancreastatin on insulin, glucagon and somatostatin secretion by the perfused rat pancreas.

    Silvestre RA, Peiró E, Miralles P, Villanueva ML, Marco J.

    Life Sci. 1988;42(14):1361-7.PMID: 2895408 [PubMed - indexed for MEDLINE]Related articles

    18.

    Tungstate stimulates insulin release and inhibits somatostatin output in the perfused rat pancreas.

    Silvestre RA, Egido EM, Hernández R, Marco J.

    Eur J Pharmacol. 2005 Sep 5;519(1-2):127-34.PMID: 16126195 [PubMed - indexed for MEDLINE]Related articles

    19.

    Glucose-dependency of the insulin stimulatory effect of glucagon-like peptide-1 (7-36) amide on the rat pancreas.

    Göke R, Wagner B, Fehmann HC, Göke B.

    Res Exp Med (Berl). 1993;193(2):97-103.PMID: 8516568 [PubMed - indexed for MEDLINE]Related articles

    20.

    Glucagon-like peptide-1 secretion is influenced by perfusate glucose concentration and by a feedback mechanism involving somatostatin in isolated perfused porcine ileum.

    Hansen L, Hartmann B, Mineo H, Holst JJ.

    Regul Pept. 2004 Apr 15;118(1-2):11-8.PMID: 14759551 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity